...
首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests.
【24h】

Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests.

机译:在2,710对不育候选夫妇中进行辅助生殖技术的基因筛查:意大利指南对基因检测的适当应用的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To report the results of the routine application of Italian guidelines that apply to infertile patient candidates for any assisted reproduction technique (ART). The guidelines recommend performing a karyotype analysis in each couple and the screening test for mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) in one of the two partners. DESIGN: Case series. SETTING: Infertility unit. PATIENT(S): Two thousand seven hundred ten consecutive infertile couple candidates for ART. INTERVENTION(S): Peripheral blood evaluation of karyotype and CFTR gene. MAIN OUTCOME MEASURE(S): Frequency of aberrant karyotype and mutated CFTR gene. RESULT(S): A total of 74 aberrant karyotypes were diagnosed, corresponding to 1.3% (95% confidence interval [CI], 0.9%-1.7%) in women and to 1.5% (95% CI, 1.0%-2.0%) in men. In men, the frequency of chromosomal abnormalities differed according to the treatment group (0.3%, 1.1%, and 2.2% in IUI, IVF, and ICSI, respectively). The same was not observed in women. Excluding the 5T variant, 3.8% of the screened patients showed a mutated CFTR gene (95% CI, 3.1%-4.5%), and the mutation was found in both partners in 0.2% of the couples (95% CI, 0.0-0.4%). CONCLUSION(S): The frequency of aberrant karyotypes is higher in infertile couples than in the general population, whereas the frequency of a mutation of the CFTR gene is similar.
机译:目的:报告常规应用意大利指南的结果,该指南适用于任何辅助生殖技术(ART)的不育患者候选人。该指南建议在每对夫妇中进行核型分析,并在两个伴侣之一中进行囊性纤维化跨膜电导调节剂(CFTR)突变的筛选测试。设计:案例系列。单位:不孕症单位。患者:2701名连续接受治疗的不育夫妇。干预:核型和CFTR基因的外周血评估。主要观察指标:核型异常和CFTR基因突变的频率。结果:总共诊断出74种异常核型,分别对应于女性的1.3%(95%置信区间[CI],0.9%-1.7%)和1.5%(95%CI,1.0%-2.0%)。在男人中。在男性中,染色体异常发生的频率因治疗组而异(IUI,IVF和ICSI分别为0.3%,1.1%和2.2%)。在女性中没有观察到同样的情况。除5T变异体外,3.8%的筛查患者显示CFTR基因突变(95%CI,3.1%-4.5%),并且在伴侣中有0.2%的夫妻发现突变(95%CI,0.0-0.4) %)。结论:不育夫妇的异常核型频率高于一般人群,而CFTR基因突变的频率相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号